Featured Research

from universities, journals, and other organizations

Most U.S. heart attack patients needing angioplasty treated within recommended time, study finds

Date:
August 22, 2011
Source:
American Heart Association
Summary:
More than 90 percent of U.S. heart attack patients who require an emergency artery-opening procedure known as angioplasty, are treated within the recommended 90 minutes, compared to less than half five years before, according to a new study. From 2005-2010, the average time from hospital admission to angioplasty decreased from 96 to 64 minutes. This significant improvement resulted from a concerted nationwide effort to improve care.

Nearly all heart attack patients who require emergency artery-opening procedures are treated within the recommended 90 minutes from hospital arrival, compared with less than half the patients five years prior, according to research reported in Circulation: Journal of the American Heart Association.

Angioplasty for these patients should be performed as quickly as possible, preferably within 90 minutes of hospital arrival. During the procedure, a doctor opens the blocked artery by passing a thin balloon-tipped tube called a catheter into the heart vessel, restoring blood flow.

The period from hospital arrival to angioplasty is called "door-to-balloon" time, also known as D2B. For ST-segment elevation myocardial infarction (STEMI) patients, quick response is critical because this type of heart attack is caused by a complete blockage of blood supply to the heart. Every year in the United States, nearly 250,000 people suffer this type of heart attack.

In one of the most comprehensive analyses of angioplasty timeliness, investigators found that:

  • 91 percent of patients were treated in a D2B time of less than 90 minutes in 2010, compared with 44 percent in 2005.
  • 70 percent were treated in less than 75 minutes in 2010, compared with 27 percent five years earlier.
  • The median time from hospital admission to emergency angioplasty declined from 96 to 64 minutes during the years studied.

"Everybody had to improve to get a national report card like this," said Harlan M. Krumholz, M.D., lead author of the study and Harold H. Hines, Jr. Professor of Medicine and Epidemiology and Public Health at Yale University School of Medicine in New Haven, Conn. "This remarkable improvement demonstrates what we can achieve when we work together and is a tribute to the doctors, nurses and other healthcare professionals that applied the information from the research studies about how best to deliver care to ensure that patients are treated rapidly."

Researchers analyzed nationwide hospital data, collected by the Centers for Medicare & Medicaid Services, from more than 300,000 patients undergoing emergency angioplasty Jan. 1, 2005, to Sept. 30, 2010, including those not covered by Medicare.

The recent progress stems from a concerted nationwide effort between federal agencies, healthcare organizations and clinicians to improve heart attack care and outcome by accelerating treatment, Krumholz said.

Several of the major initiatives include:

  • Hospital Compare, launched in September 2005 as part of The Centers for Medicare & Medicaid Services' program to publicly report the percentage of patients treated within recommended times;
  • D2B Alliance, launched in November 2006 by the American College of Cardiology with national partners to improve D2B times by advocating the adoption of key strategies shown to reduce delays based on a study funded by the National Heart, Lung, and Blood Institute;
  • Mission: Lifeline, launched in May 2007 by the American Heart Association to improve community-wide systems of care for patients with STEMI. Through Mission: Lifeline, systems of care are working to get patients to call 9-1-1 faster, to improve the response time and capabilities of the emergency medical service teams, to provide faster triage and transport from hospitals that don't provide angioplasty to those that do, and to ensure the receiving hospitals' team is in place ready to treat the patient as quickly as possible upon arrival.

"The findings of this study are remarkable in that there has been a dramatic improvement in timely care of heart attacks across the entire country," said Chris Granger, M.D., chairman of the Mission: Lifeline steering committee and Professor of Medicine and director of the Cardiac Care Unit at Duke University Medical Center in Durham, N.C. "It shows what can be accomplished with systematic quality improvement efforts based on sound evidence.

The results of this study reinforce the value of ongoing efforts to extend these improvements to emergency medical services, networks of hospitals and to all aspects of care of heart attacks, as is now being done in Mission: Lifeline."

"At the beginning of these efforts, many said that this level of improvement was impossible to achieve," Krumholz said. "This is an opportunity to reflect on our achievement and to recognize that, when we identify quality issues and problems in our healthcare system, we can work as a community to generate new knowledge to apply to practice and improve care for patients."

Co-authors are Jeph Herrin, Ph.D.; Lauren E. Miller, M.S.; Elizabeth E. Drye, M.D., S.M.; Shari M. Ling, M.D.; Lein F. Han, Ph.D.; Michael T. Rapp, M.D., J.D.; Elizabeth H. Bradley, Ph.D.; Brahmajee K. Nallamothu, M.D., M.P.H.; Wato Nsa, M.D., Ph.D.; Dale W. Bratzler, D.O., M.P.H.; Jeptha P. Curtis, M.D. Author disclosures are on the manuscript.

The Centers for Medicare & Medicaid Services and the National Heart, Lung, and Blood Institute funded the study.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Journal Reference:

  1. Harlan M. Krumholz, Jeph Herrin, Lauren E. Miller, Elizabeth E. Drye, Shari M. Ling, Lein F. Han, Michael T. Rapp, Elizabeth H. Bradley, Brahmajee K. Nallamothu, Wato Nsa, Dale W. Bratzler, Jeptha P. Curtis. Improvements in Door-to-Balloon Time in the United States, 2005 to 2010. Circulation, 2011; DOI: 10.1161/CIRCULATIONAHA.111.044107

Cite This Page:

American Heart Association. "Most U.S. heart attack patients needing angioplasty treated within recommended time, study finds." ScienceDaily. ScienceDaily, 22 August 2011. <www.sciencedaily.com/releases/2011/08/110822161336.htm>.
American Heart Association. (2011, August 22). Most U.S. heart attack patients needing angioplasty treated within recommended time, study finds. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2011/08/110822161336.htm
American Heart Association. "Most U.S. heart attack patients needing angioplasty treated within recommended time, study finds." ScienceDaily. www.sciencedaily.com/releases/2011/08/110822161336.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

More Coverage


Heart Attack Patients Winning the Race to Angioplasty Treatment, U.S. Study Finds

Aug. 22, 2011 Almost all heart attack patients who need the emergency artery-opening procedure known as angioplasty are receiving it within 90 minutes of being admitted to the hospital, a marked improvement from ... read more
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins